US2021353542A1PendingUtilityA1

Methods and Compositions for Administering an Active Agent to the Pleura of a Patient

62
Assignee: TDL INNOVATIONS LLCPriority: Apr 1, 2014Filed: Dec 7, 2020Published: Nov 18, 2021
Est. expiryApr 1, 2034(~7.7 yrs left)· nominal 20-yr term from priority
Inventors:Glenn W. Laub
A61K 47/36A61K 47/42A61K 47/10A61K 38/14A61K 9/122A61K 31/65A61K 9/0019A61K 33/18A61K 9/124A61K 31/79
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for administering an active agent to a pleura of a patient includes preparing a composition including a foamable liquid and the active agent, incorporating a gas into the foamable liquid to create a foam containing the active agent, introducing the foam into a pleural cavity of the patient defined by the pleura, and contacting the pleura with the foam. A method of pleurodesis includes introducing a composition into a pleural cavity defined by pleurae of a patient, the composition including a foamable liquid and an active agent capable of causing inflammation and/or adhesion of the pleurae. A composition for treating a pleura of a patient includes a liquid component including a biocompatible composition having a viscosity which increases in response to an increase in temperature, and an active agent capable of causing inflammation and/or adhesion of the pleura.

Claims

exact text as granted — not AI-modified
1 . A composition for treating a pleura of a patient, the composition comprising: a liquid component comprising a biocompatible composition having a viscosity which increases in response to an increase in temperature; and an active agent dissolved, dispersed, or suspended in the liquid component, the active agent being capable of causing inflammation and/or adhesion of the pleura. 
     
     
         2 .- 71 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.